Angiogenesis |
VEGFA, THBS1, HIF1A, MMP2, TWIST1
|
30.3% |
Apoptosis |
PTRH2, CAV1, MMP11, SRC, TP53
|
75.8% |
Cell cycle |
CCNB1, CDK1, CDK2, CDK4, CCNA1
|
69.7% |
Epigenetics |
GREB1, HMGCS2, TFF3, TSSC4, JUNB
|
21.2% |
Genotoxicity |
EXO1, ATM, XRCC5, RAD51, BRIP1
|
39.4% |
Growth hormones |
IGF1, GH2, GH1, GHR, CSH2
|
30.3% |
Immortalization |
BCL2L1, BCL2, ZNF165, ARMC1, BIRC5
|
30.3% |
Immunomodulation |
IL2, CD69, GATA3, CD38, CSF1
|
48.5% |
Inflammation |
IL6, PYCARD, IL1B, F3, IL8
|
54.5% |
Mammary |
BRCA2, BRCA1, PRLR, PRL, ERBB2
|
39.4% |
Oxidative stress |
NOL3, HMOX1, CAT, ENO1, HSPA8
|
42.4% |
Proliferation |
NOTCH1, MYC, CTNNB1, TBX3, CCND2
|
36.7% |
Steroid hormones |
ESR1, ESR2, PGR, CYP17A1, STS
|
51.5% |
Xenobiotic metabolism |
NR1I3, NR1I2, EPHX1, NAT1, CYP1A2
|
81.8% |